Long-term storage of lipid-like nanoparticles for mRNA delivery

Li, 2019, Nanoscale platforms for messenger RNA delivery, Wiley Interdiscipl. Rev.: Nanomed. Nanobiotechnol., 11 Patel, 2019, Messenger RNA delivery for tissue engineering and regenerative medicine applications, Tissue Eng., 25, 91, 10.1089/ten.tea.2017.0444 Xiong, 2018, Biomedical applications of mRNA nanomedicine, Nano Res., 11, 5281, 10.1007/s12274-018-2146-1 Hajj, 2017, Tools for translation: non-viral materials for therapeutic mRNA delivery, Nat. Rev. Mater., 2, 1, 10.1038/natrevmats.2017.56 Granot-Matok, 2019, Therapeutic mRNA delivery to leukocytes, J. Contr. Release, 305, 165, 10.1016/j.jconrel.2019.05.032 Zhao, 2018, Lipid polymer hybrid nanomaterials for mRNA delivery, Cell. Mol. Bioeng., 11, 397, 10.1007/s12195-018-0536-9 Zhao, 2019, 119291 Islam, 2018, Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA, Nat. Biomed. Eng., 2, 850, 10.1038/s41551-018-0284-0 Patel, 2019, Lipid nanoparticles for delivery of messenger RNA to the back of the eye, J. Contr. Release, 303, 91, 10.1016/j.jconrel.2019.04.015 Sago, 2018, High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing, Proc. Natl. Acad. Sci. Unit. States Am., 115, E9944, 10.1073/pnas.1811276115 Cheng, 2012, Multifunctional triblock copolymers for intracellular messenger RNA delivery, Biomaterials, 33, 6868, 10.1016/j.biomaterials.2012.06.020 Phua, 2013, Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format, J. Contr. Release, 166, 227, 10.1016/j.jconrel.2012.12.029 Su, 2011, In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles, Mol. Pharm., 8, 774, 10.1021/mp100390w Wang, 2013, Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy, Mol. Ther., 21, 358, 10.1038/mt.2012.250 Kranz, 2016, Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy, Nature, 534, 396, 10.1038/nature18300 Li, 2015, An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo, Nano Lett., 15, 8099, 10.1021/acs.nanolett.5b03528 Zhang, 2019, Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer, Nano Res., 12, 855, 10.1007/s12274-019-2308-9 Cheng, 2018, Dendrimer‐based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I, Adv. Mater., 30, 1805308, 10.1002/adma.201805308 Ball, 2017, Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization, Int. J. Nanomed., 12, 305, 10.2147/IJN.S123062 Aso, 2005, Effect of freezing rate on physical stability of lyophilized cationic liposomes, Chem. Pharm. Bull., 53, 301, 10.1248/cpb.53.301 Chen, 2010, An overview of liposome lyophilization and its future potential, J. Contr. Release, 142, 299, 10.1016/j.jconrel.2009.10.024 del Pozo-Rodríguez, 2009, Short-and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy, Eur. J. Pharm. Biopharm., 71, 181, 10.1016/j.ejpb.2008.09.015 Kasper, 2013, Recent advances and further challenges in lyophilization, Eur. J. Pharm. Biopharm., 85, 162, 10.1016/j.ejpb.2013.05.019 Stark, 2010, Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structure, Eur. J. Pharmaceut. Sci., 41, 546, 10.1016/j.ejps.2010.08.010 Yin, 2014, Preparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factor, Int. J. Nanomed., 9, 1665 Anchordoquy, 2000, Physical stability of nonviral plasmid‐based therapeutics, J. Pharm. Sci., 89, 289, 10.1002/(SICI)1520-6017(200003)89:3<289::AID-JPS1>3.0.CO;2-N Howard, 2012, Optimization of the lyophilization process for long-term stability of solid–lipid nanoparticles, Drug Dev. Ind. Pharm., 38, 1270, 10.3109/03639045.2011.645835 Fonte, 2012, Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying, Biomatter, 2, 329, 10.4161/biom.23246 Radmanovic, 2013, Understanding the freezing of biopharmaceuticals: first-principle modeling of the process and evaluation of its effect on product quality, J. Pharm. Sci., 102, 2495, 10.1002/jps.23642 Hengherr, 2008, Trehalose and anhydrobiosis in tardigrades–evidence for divergence in responses to dehydration, FEBS J., 275, 281, 10.1111/j.1742-4658.2007.06198.x Jeong, 2005, Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly (DL-lactide-co-glycolide), J. Microencapsul., 22, 593, 10.1080/02652040500162659 Lee, 2009, Cryoprotectants for freeze drying of drug nano‐suspensions: effect of freezing rate, J. Pharm. Sci., 98, 4808, 10.1002/jps.21786 Shi, 2012, The effect of annealing and cryoprotectants on the properties of vacuum-freeze dried starch nanoparticles, Carbohydr. Polym., 88, 1334, 10.1016/j.carbpol.2012.02.013 Akinc, 2010, Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms, Mol. Ther., 18, 1357, 10.1038/mt.2010.85